Pharma business development for Galapagos after raising $70 million through a private placement of new shares. Read the full story

Big pharma and big biotech company, Roche, said it and Ascletis have entered into a pharma business development agreement for developing and marketing Roche's investigational drug danoprevir in China. Read the full story

Merck and Samsung Bioepis entered into a pharma business development agreement to develop and commercialize multiple pre-specified and undisclosed biosimilar candidates. Read the full story

Roche, a big pharma company, is in partnership to develop and commercialize Chiasma's proprietary product Octreolin, initially for acromegaly and subsequently for neuroendocrine tumors. Read the full story